
Zydus Lifesciences to launch vaccine VaxiFlu-4 to India
Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus vaccines for use in the Southern Hemisphere in 2025. The pharmaceutical company’s quadrivalent inactivated influenza vaccine, VaxiFlu-4, has been developed at the Vaccine Technology Centre (VTC) in...
Read more